January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Contributing to the German beauty company’s strong growth trajectory were its U.S. business and social media backing.

European stocks closed mostly higher on Wednesday with investors shrugging off concerns about tariffs for now and focusing on ...

A summary of the latest financial news from European markets, including stock performance, unemployment rates, trade surplus, bond yields, and ...

Sustainable prospects for the majority of staff at the siteFirst staff takeovers and start of production at KNDS already planned for 2025 5 February, 2025 - The negotiations between Alstom and KNDS De ...

The yen gained against the greenback and gold rose to a record high on haven demand. The 10-year Treasury yield dipped and an index of dollar strength extended losses, after US job openings fell in ...

Santander (BME: SAN) stock soared over 6% after the Spanish lender reported record annual profits for the third consecutive ...

US equity futures dropped as investors navigate the trade war and a busy slate of earnings from some of the world’s biggest ...

(Reuters) - European shares were flat in early trade on Wednesday, as gains led by healthcare stocks following drugmaker Novo ...

In early UK corporate news, GSK announced a buyback and upped its 2031 sales target. Here is what you need to know at the London market open: FTSE 100: called down 0.3% at 8,542.57 Hang Seng: down 1.0 ...

European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.